Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
Integrated Biopharma reports 2019 executive compensation
By ExecPay News
Published: October 28, 2019
Integrated Biopharma reported fiscal year 2019 executive compensation information on October 28, 2019.
In 2019, four executives at Integrated Biopharma received on average a compensation package of $225K, a 8% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $251K in total, which increased by 4% compared to 2018. 92% of Masi's compensation, or $231K, was in salary. Masi also received $11K in option awards and $8.8K in other compensation.
E.Gerald Kay, Chief Executive Officer, received a compensation package of $243K, which increased by 8% compared to previous year. 81% of the compensation package, or $198K, was in salary.
Christina Kay, Chief Executive Officer, earned $205K in 2019, a 10% increase compared to previous year.
Riva Sheppard, Chief Executive Officer, received $203K in 2019, which increases by 11% compared to 2018.
Integrated Biopharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 28, 2019.